These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
383 related articles for article (PubMed ID: 15070702)
1. Leukemic transformation of hematopoietic progenitors by MLL-GAS7 in the absence of Hoxa7 or Hoxa9. So CW; Karsunky H; Wong P; Weissman IL; Cleary ML Blood; 2004 Apr; 103(8):3192-9. PubMed ID: 15070702 [TBL] [Abstract][Full Text] [Related]
2. Transformation of myeloid progenitors by MLL oncoproteins is dependent on Hoxa7 and Hoxa9. Ayton PM; Cleary ML Genes Dev; 2003 Sep; 17(18):2298-307. PubMed ID: 12952893 [TBL] [Abstract][Full Text] [Related]
3. PBX3 and MEIS1 Cooperate in Hematopoietic Cells to Drive Acute Myeloid Leukemias Characterized by a Core Transcriptome of the MLL-Rearranged Disease. Li Z; Chen P; Su R; Hu C; Li Y; Elkahloun AG; Zuo Z; Gurbuxani S; Arnovitz S; Weng H; Wang Y; Li S; Huang H; Neilly MB; Wang GG; Jiang X; Liu PP; Jin J; Chen J Cancer Res; 2016 Feb; 76(3):619-29. PubMed ID: 26747896 [TBL] [Abstract][Full Text] [Related]
4. Persistent transactivation by meis1 replaces hox function in myeloid leukemogenesis models: evidence for co-occupancy of meis1-pbx and hox-pbx complexes on promoters of leukemia-associated genes. Wang GG; Pasillas MP; Kamps MP Mol Cell Biol; 2006 May; 26(10):3902-16. PubMed ID: 16648484 [TBL] [Abstract][Full Text] [Related]
5. Retrovirus-mediated gene transfer of MLL-ELL transforms primary myeloid progenitors and causes acute myeloid leukemias in mice. Lavau C; Luo RT; Du C; Thirman MJ Proc Natl Acad Sci U S A; 2000 Sep; 97(20):10984-9. PubMed ID: 10995463 [TBL] [Abstract][Full Text] [Related]
6. Mll partial tandem duplication induces aberrant Hox expression in vivo via specific epigenetic alterations. Dorrance AM; Liu S; Yuan W; Becknell B; Arnoczky KJ; Guimond M; Strout MP; Feng L; Nakamura T; Yu L; Rush LJ; Weinstein M; Leone G; Wu L; Ferketich A; Whitman SP; Marcucci G; Caligiuri MA J Clin Invest; 2006 Oct; 116(10):2707-16. PubMed ID: 16981007 [TBL] [Abstract][Full Text] [Related]
7. MLL-GAS7 transforms multipotent hematopoietic progenitors and induces mixed lineage leukemias in mice. So CW; Karsunky H; Passegué E; Cozzio A; Weissman IL; Cleary ML Cancer Cell; 2003 Feb; 3(2):161-71. PubMed ID: 12620410 [TBL] [Abstract][Full Text] [Related]
8. A carboxy-terminal domain of ELL is required and sufficient for immortalization of myeloid progenitors by MLL-ELL. DiMartino JF; Miller T; Ayton PM; Landewe T; Hess JL; Cleary ML; Shilatifard A Blood; 2000 Dec; 96(12):3887-93. PubMed ID: 11090074 [TBL] [Abstract][Full Text] [Related]
9. Expression of HOX genes, HOX cofactors, and MLL in phenotypically and functionally defined subpopulations of leukemic and normal human hematopoietic cells. Kawagoe H; Humphries RK; Blair A; Sutherland HJ; Hogge DE Leukemia; 1999 May; 13(5):687-98. PubMed ID: 10374871 [TBL] [Abstract][Full Text] [Related]
10. Meis1 is an essential and rate-limiting regulator of MLL leukemia stem cell potential. Wong P; Iwasaki M; Somervaille TC; So CW; Cleary ML Genes Dev; 2007 Nov; 21(21):2762-74. PubMed ID: 17942707 [TBL] [Abstract][Full Text] [Related]
11. The small oligomerization domain of gephyrin converts MLL to an oncogene. Eguchi M; Eguchi-Ishimae M; Greaves M Blood; 2004 May; 103(10):3876-82. PubMed ID: 14751928 [TBL] [Abstract][Full Text] [Related]
12. PBX3 is an important cofactor of HOXA9 in leukemogenesis. Li Z; Zhang Z; Li Y; Arnovitz S; Chen P; Huang H; Jiang X; Hong GM; Kunjamma RB; Ren H; He C; Wang CZ; Elkahloun AG; Valk PJ; Döhner K; Neilly MB; Bullinger L; Delwel R; Löwenberg B; Liu PP; Morgan R; Rowley JD; Yuan CS; Chen J Blood; 2013 Feb; 121(8):1422-31. PubMed ID: 23264595 [TBL] [Abstract][Full Text] [Related]
13. Dimerization contributes to oncogenic activation of MLL chimeras in acute leukemias. So CW; Lin M; Ayton PM; Chen EH; Cleary ML Cancer Cell; 2003 Aug; 4(2):99-110. PubMed ID: 12957285 [TBL] [Abstract][Full Text] [Related]
14. Nup98-HoxA9 immortalizes myeloid progenitors, enforces expression of Hoxa9, Hoxa7 and Meis1, and alters cytokine-specific responses in a manner similar to that induced by retroviral co-expression of Hoxa9 and Meis1. Calvo KR; Sykes DB; Pasillas MP; Kamps MP Oncogene; 2002 Jun; 21(27):4247-56. PubMed ID: 12082612 [TBL] [Abstract][Full Text] [Related]
15. Expression of HOX genes in acute leukemia cell lines with and without MLL translocations. Quentmeier H; Dirks WG; Macleod RA; Reinhardt J; Zaborski M; Drexler HG Leuk Lymphoma; 2004 Mar; 45(3):567-74. PubMed ID: 15160920 [TBL] [Abstract][Full Text] [Related]
16. Gene expression signatures in MLL-rearranged T-lineage and B-precursor acute leukemias: dominance of HOX dysregulation. Ferrando AA; Armstrong SA; Neuberg DS; Sallan SE; Silverman LB; Korsmeyer SJ; Look AT Blood; 2003 Jul; 102(1):262-8. PubMed ID: 12637319 [TBL] [Abstract][Full Text] [Related]
17. Dimerization of MLL fusion proteins and FLT3 activation synergize to induce multiple-lineage leukemogenesis. Ono R; Nakajima H; Ozaki K; Kumagai H; Kawashima T; Taki T; Kitamura T; Hayashi Y; Nosaka T J Clin Invest; 2005 Apr; 115(4):919-29. PubMed ID: 15761502 [TBL] [Abstract][Full Text] [Related]
18. Targeted down-regulation of MLL-AF9 with antisense oligodeoxyribonucleotide reduces the expression of the HOXA7 and -A10 genes and induces apoptosis in a human leukemia cell line, THP-1. Kawagoe H; Kawagoe R; Sano K Leukemia; 2001 Nov; 15(11):1743-9. PubMed ID: 11681416 [TBL] [Abstract][Full Text] [Related]
19. Upregulation of Meis1 and HoxA9 in acute lymphocytic leukemias with the t(4 : 11) abnormality. Rozovskaia T; Feinstein E; Mor O; Foa R; Blechman J; Nakamura T; Croce CM; Cimino G; Canaani E Oncogene; 2001 Feb; 20(7):874-8. PubMed ID: 11314021 [TBL] [Abstract][Full Text] [Related]
20. MLL is essential for NUP98-HOXA9-induced leukemia. Shima Y; Yumoto M; Katsumoto T; Kitabayashi I Leukemia; 2017 Oct; 31(10):2200-2210. PubMed ID: 28210005 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]